2014
Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World
SHAH, Ravi; Etienne GAYAT; James L. JANUZZI; Naoki SATO; Alain COHEN-SOLAL et al.Základní údaje
Originální název
Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World
Autoři
SHAH, Ravi; Etienne GAYAT; James L. JANUZZI; Naoki SATO; Alain COHEN-SOLAL; Salvatore DISOMMA; Enrique FAIRMAN; Veli-Pekka HARJOLA; Shiro ISHIHARA; Johan LASSUS; Aldo MAGGIONI; Marco METRA; Christian MUELLER; Thomas MUELLER; Jiří PAŘENICA; Domingo PASCUAL-FIGAL; Frank PEACOCK; Jindřich ŠPINAR; Roland van KIMMENADE a Alexandre MEBAZAA
Vydání
Journal of The American College of Cardiology, NEW YORK, Elsevier Science, 2014, 0735-1097
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 16.503
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/14:00074969
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
heart failure; obesity; obesity paradox
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 15. 4. 2014 12:00, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Objective To define the relationship between body mass index (BMI) and mortality in heart failure (HF) across the world and identify specific groups in whom BMI may differentially mediate risk. Background Obesity is associated with incident heart failure (HF), but is paradoxically associated with better prognosis during chronic HF. Methods We studied 6,142 patients with acute decompensated HF from 12 prospective observational cohorts followed across 4 continents. Primary outcome was all-cause mortality. Cox proportional hazards models and net reclassification index (NRI) described associations of BMI with all-cause mortality. Results “Normal” weight patients (BMI 18.5-25 kg/m2) were older with more advanced HF and lower cardiometabolic risk. Despite worldwide heterogeneity in clinical features across obesity categories, a higher BMI remained associated with decreased 30-day and 1-year mortality (11% decrease at 30 days; 9% decrease at 1 year per 5 kg/m2; P<0.05), after adjustment for clinical risk. BMI obtained at index admission provided effective 1-year risk reclassification beyond current markers of clinical risk (NRI 0.119, P <.001). Notably, the “protective” association of BMI with mortality was confined to those with older age (>75; HR=0.82, P=0.006), decreased cardiac function (ejection fraction < 50%; HR=0.85, P<.001), non-diabetics (HR=0.86, P<.001), and de novo HF (HR=0.89, P=0.004). Conclusions A lower BMI is associated with age, disease severity, and a higher risk of death in ADHF. The “obesity paradox” is confined to older individuals, decreased cardiac function, less cardiometabolic illness, and recent onset HF, suggesting that aging, HF severity/chronicity, and metabolism may explain the obesity paradox.